Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

174
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
174
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

206
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
206
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

604
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
604
Angina IV: Management01:26

Angina IV: Management

189
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
189
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

295
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
295
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

152
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
152

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

UGT1A1 genotype testing for irinotecan: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).

British journal of clinical pharmacology·2026
Same author

Durvalumab in Combination With Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: Long-Term Analysis From the GeparNuevo Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Prospective Follow-Up Assessment of Wrist Function After the Transradial Approach for Diagnostic Cerebral Catheter Angiography.

Journal of clinical medicine·2026
Same author

Corrigendum to "A clinical rule-based indicator to identify recurrence of colorectal cancer after curative resection using linked routinely collected national data" [Cancer Epidemiol. 100 (2026) 102962].

Cancer epidemiology·2026
Same author

Refining Risk Assessment for Adjuvant CDK4/6 Inhibitors beyond Trial Inclusion Criteria: Integrating Recurrence Score and Endocrine Responsiveness according to ADAPT.

Breast care (Basel, Switzerland)·2026
Same author

A Descriptive Review of Education Theories and Frameworks in Health Professions Education Research.

Medical science educator·2026

Related Experiment Video

Updated: Dec 26, 2025

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.6K

Acute Coronary Syndrome: Management.

Michael Braun1, David Kassop2

  • 1Madigan Army Medical Center Family Medicine Residency Program, 9040 Jackson Ave, Tacoma, WA 98431.

FP Essentials
|March 10, 2020
PubMed
Summary

This study outlines recommended treatments for acute coronary syndrome (ACS), emphasizing dual antiplatelet therapy, anticoagulation, and timely percutaneous coronary intervention (PCI) or fibrinolytic therapy for ST-elevation myocardial infarction.

More Related Videos

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.4K
Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.6K

Related Experiment Videos

Last Updated: Dec 26, 2025

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.6K
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.4K
Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.6K

Area of Science:

  • Cardiology
  • Internal Medicine
  • Emergency Medicine

Background:

  • Acute coronary syndrome (ACS) requires prompt and evidence-based management.
  • Current guidelines recommend a multi-faceted approach involving antiplatelet and anticoagulation therapies.
  • Risk stratification is crucial for guiding treatment decisions and preventing complications.

Purpose of the Study:

  • To summarize the recommended medical and interventional therapies for patients presenting with acute coronary syndrome (ACS).
  • To provide guidance on the optimal timing and selection of treatments, including antiplatelet agents, anticoagulants, and revascularization strategies.
  • To highlight the importance of gastrointestinal bleeding prophylaxis and management of associated symptoms.

Main Methods:

  • Review of current clinical guidelines and evidence-based recommendations for ACS management.
  • Synthesis of data regarding the efficacy and safety of various pharmacological agents, including aspirin, P2Y12 inhibitors, and anticoagulants.
  • Analysis of indications and contraindications for revascularization procedures such as percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG).

Main Results:

  • Aspirin is universally recommended for suspected ACS, with dual antiplatelet therapy (DAPT) advised for most patients.
  • Parenteral anticoagulation options include unfractionated heparin, low-molecular-weight heparin, bivalirudin, and fondaparinux.
  • Proton pump inhibitors are recommended for high-risk patients to prevent gastrointestinal bleeding.
  • For ST-elevation myocardial infarction (STEMI), immediate PCI is preferred; fibrinolysis is an alternative if PCI is delayed.
  • For non-ST-elevation ACS, PCI is generally recommended, while fibrinolysis is typically not indicated.
  • Coronary artery bypass grafting (CABG) is usually delayed 3-7 days post-admission unless specific high-risk criteria are met.

Conclusions:

  • Optimal ACS management involves a combination of antiplatelet and anticoagulation therapies, tailored to individual patient risk.
  • Timely revascularization, preferably via PCI, is critical for STEMI patients.
  • Careful consideration of bleeding risk and appropriate prophylaxis are essential components of ACS care.
  • Coronary artery bypass grafting decisions should be individualized based on clinical presentation and coronary anatomy.